Surgical Science Sweden AB (publ) (STO:SUS)
30.84
+0.64 (2.12%)
Jul 24, 2026, 5:29 PM CET
STO:SUS Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 667.73 | 616.43 | 968.16 | 634.37 | 433.73 | 316.68 |
Cash & Short-Term Investments | 667.73 | 616.43 | 968.16 | 634.37 | 433.73 | 316.68 |
Cash Growth | 8.95% | -36.33% | 52.62% | 46.26% | 36.96% | 263.34% |
Accounts Receivable | 122.83 | 136.98 | 136.7 | 110.6 | 176.31 | 110.65 |
Other Receivables | 71.06 | 71.27 | 43.65 | 18.85 | 17.8 | 22.32 |
Total Trade Receivables | 193.89 | 208.25 | 180.35 | 129.45 | 194.11 | 132.96 |
Inventory | 207.5 | 205.97 | 179.58 | 154.45 | 134.88 | 113.11 |
Other Current Assets | 117.47 | 154.04 | 97.91 | 72.92 | 63.65 | 54.16 |
Total Current Assets | 1,187 | 1,185 | 1,426 | 991.19 | 826.37 | 616.91 |
Net Property, Plant & Equipment | 112.43 | 106.35 | 101.53 | 76.62 | 51.36 | 38.39 |
Other Intangible Assets | 307.7 | 300.9 | 311.91 | 286.57 | 301.02 | 274.03 |
Goodwill | 3,174 | 3,077 | 3,616 | 3,329 | 3,444 | 3,019 |
Long-Term Investments | 8.98 | 8.62 | 8.05 | 4.77 | 4.37 | 4.97 |
Other Long-Term Assets | 14.43 | 13.58 | 16.33 | 14.84 | 22.16 | 24.6 |
Total Assets | 4,804 | 4,691 | 5,480 | 4,703 | 4,650 | 3,978 |
Accounts Payable | - | 36.25 | 58.45 | 41.29 | 65.69 | 34.37 |
Accrued Expenses | - | 152.99 | 124.95 | 120.23 | 114.92 | 121.13 |
Short-Term Debt | 2.15 | - | - | - | - | - |
Other Current Liabilities | 265.26 | 103.53 | 329.33 | 73.42 | 125.3 | 76.88 |
Total Current Liabilities | 267.41 | 292.76 | 512.72 | 234.94 | 305.91 | 232.38 |
Other Long-Term Liabilities | - | 291.7 | 926.87 | 559.3 | 688.34 | 278.41 |
Total Long-Term Liabilities | 121.32 | 125.55 | 138.31 | 122.52 | 107.2 | 160.68 |
Total Liabilities | 388.73 | 418.31 | 651.04 | 357.46 | 413.11 | 393.06 |
Common Stock | - | 2.55 | 2.55 | 2.55 | 2.54 | 2.54 |
Additional Paid-in Capital | - | 3,398 | 3,398 | 3,398 | 3,379 | 3,379 |
Retained Earnings | - | 706.23 | 639.41 | 507.76 | 273.79 | 85.82 |
Shareholders' Equity | 4,416 | 4,273 | 4,829 | 4,345 | 4,236 | 3,585 |
Total Liabilities & Equity | 4,804 | 4,691 | 5,480 | 4,703 | 4,650 | 3,978 |
Total Debt | 2.15 | 0 | 0 | 0 | 0 | 0 |
Net Cash (Debt) | 665.58 | 616.43 | 968.16 | 634.37 | 433.73 | 316.68 |
Net Cash Growth | 8.89% | -36.33% | 52.62% | 46.26% | 36.96% | 263.34% |
Net Cash Per Share | 13.04 | 12.08 | 18.97 | 12.45 | 8.52 | 7.42 |
Book Value | 4,416 | 4,273 | 4,829 | 4,345 | 4,236 | 3,585 |
Book Value Per Share | 86.53 | 83.74 | 94.63 | 85.30 | 83.21 | 84.02 |
Tangible Book Value | 933.69 | 894.92 | 900.89 | 729.96 | 491.14 | 291.81 |
Tangible Book Value Per Share | 18.30 | 17.54 | 17.66 | 14.33 | 9.65 | 6.84 |